Pharmacokinetics and pharmacodynamics of ASP2151, a helicase-primase inhibitor, in a murine model of herpes simplex virus infection.
about
New strategies against drug resistance to herpes simplex virusThe DNA helicase-primase complex as a target for herpes viral infectionPreclinical pharmacokinetics of MHAA4549A, a human monoclonal antibody to influenza A virus, and the prediction of its efficacious clinical dose for the treatment of patients hospitalized with influenza A.Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymeraseHelicase-primase as a target of new therapies for herpes simplex virus infections.Statistical analysis of Amenamevir (ASP2151) between pharmacokinetics and clinical efficacies with non-linear effect model for the treatment of genital herpes.Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies.The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies.Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults.Experimental Dissection of the Lytic Replication Cycles of Herpes Simplex Viruses
P2860
Q26749548-3EC062B3-16E8-41E8-8DB8-9D61337A1B99Q26849412-FA1FDF22-BAF4-4D39-9559-E102594354E0Q37286996-DF152078-28E1-4F22-AC0C-B8AFB30350A6Q37523020-BABAD006-1701-47F8-892F-0FB76954403AQ38351481-A8955283-ADB5-403D-A08F-CDA8C93294B4Q42195768-BA836487-6497-4632-B2B0-BCB0C10779DCQ47108365-AF0FD62E-4F45-4B0F-B746-7B414C57E830Q47133959-F060BCE8-8595-43B8-8C8D-3F9D33B4FF7AQ47598353-9C9CDCD6-588C-417E-AEE8-B6FA27B23968Q58572935-5C8853B9-1050-4A58-AC60-05D68581B5ED
P2860
Pharmacokinetics and pharmacodynamics of ASP2151, a helicase-primase inhibitor, in a murine model of herpes simplex virus infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Pharmacokinetics and pharmacod ...... erpes simplex virus infection.
@ast
Pharmacokinetics and pharmacod ...... erpes simplex virus infection.
@en
type
label
Pharmacokinetics and pharmacod ...... erpes simplex virus infection.
@ast
Pharmacokinetics and pharmacod ...... erpes simplex virus infection.
@en
prefLabel
Pharmacokinetics and pharmacod ...... erpes simplex virus infection.
@ast
Pharmacokinetics and pharmacod ...... erpes simplex virus infection.
@en
P2093
P2860
P356
P1476
Pharmacokinetics and pharmacod ...... erpes simplex virus infection.
@en
P2093
Hiroshi Suzuki
Kiyomitsu Katsumata
Koji Chono
Shoji Takakura
Toru Kontani
Yoshiaki Ohtsu
P2860
P304
P356
10.1128/AAC.01803-12
P407
P577
2012-12-28T00:00:00Z